Read the latest positive news, breakthroughs, and inspiring stories about inflammation research, curated daily by BrightWire.
Researchers at Boston Children's Hospital discovered that inflammation happens after proteins leave immune receptors, not during contact with them. This breakthrough could finally lead to effective treatments for autoimmune diseases after decades of failed attempts.
Scientists discovered that GDF15, a hormone known for weight loss, can actually shield the liver from dangerous inflammation through a completely separate pathway. This finding could help millions living with advanced fatty liver disease who still face inflammation even after losing weight.
Scientists are celebrating a major medical breakthrough: chronic inflammation appears to be a root cause of numerous diseases, opening doors to new treatments. This finding could reshape how doctors approach everything from heart disease to mental health.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
Ozempic and similar medications may heal arthritis, liver disease, and more by resetting the immune system, not just through weight loss. Scientists are discovering these drugs work throughout the body to reduce harmful inflammation while keeping infection-fighting power strong.
Scientists discovered that keratin 16 acts as a natural "brake" on skin inflammation, explaining why mutations cause painful conditions like psoriasis and eczema. This breakthrough could lead to targeted treatments for millions suffering from inflammatory skin diseases.
A groundbreaking clinical trial has begun testing an oral medication that could slow Parkinson's disease progression by targeting inflammation in the brain. The drug has already shown a remarkable safety record across multiple disease trials.
Researchers discovered how the body naturally shuts down inflammation using fat-based molecules, opening doors to safer treatments for arthritis and heart disease. The human trial showed that boosting these protective molecules reduced pain faster without suppressing overall immunity.
Scientists at Washington State University discovered why common arthritis drugs fail for 40% of patients and found a promising path to better treatments. The breakthrough reveals a "backdoor" inflammation pathway that could transform care for millions worldwide.
Researchers have identified a natural molecule that could halt chronic inflammation linked to heart disease, diabetes, and autoimmune conditions. Clinical trials may be on the horizon for this groundbreaking discovery.
Researchers discovered how fat-based molecules naturally stop inflammation, offering hope for millions suffering from arthritis, heart disease, and diabetes. A human trial showed the breakthrough could lead to safer treatments that calm the immune system without weakening it.